HU207439B - Method for producing micro-capsuled medicine preparations - Google Patents
Method for producing micro-capsuled medicine preparations Download PDFInfo
- Publication number
- HU207439B HU207439B HU874335A HU433587A HU207439B HU 207439 B HU207439 B HU 207439B HU 874335 A HU874335 A HU 874335A HU 433587 A HU433587 A HU 433587A HU 207439 B HU207439 B HU 207439B
- Authority
- HU
- Hungary
- Prior art keywords
- insulin
- active ingredient
- stable
- proteinaceous
- microspheres
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/559—Redox delivery systems, e.g. dihydropyridine pyridinium salt redox systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89736186A | 1986-08-18 | 1986-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT52947A HUT52947A (en) | 1990-09-28 |
HU207439B true HU207439B (en) | 1993-04-28 |
Family
ID=25407824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU874335A HU207439B (en) | 1986-08-18 | 1987-08-14 | Method for producing micro-capsuled medicine preparations |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR950009089B1 (ko) |
CN (1) | CN1034858A (ko) |
DK (1) | DK205988A (ko) |
FI (1) | FI102456B1 (ko) |
HU (1) | HU207439B (ko) |
-
1987
- 1987-08-14 HU HU874335A patent/HU207439B/hu not_active IP Right Cessation
- 1987-08-14 KR KR1019880700407A patent/KR950009089B1/ko not_active IP Right Cessation
-
1988
- 1988-02-11 CN CN88100864A patent/CN1034858A/zh active Pending
- 1988-04-15 DK DK205988A patent/DK205988A/da not_active Application Discontinuation
-
1989
- 1989-02-17 FI FI890782A patent/FI102456B1/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI102456B (fi) | 1998-12-15 |
CN1034858A (zh) | 1989-08-23 |
HUT52947A (en) | 1990-09-28 |
FI890782A (fi) | 1989-02-17 |
DK205988D0 (da) | 1988-04-15 |
FI102456B1 (fi) | 1998-12-15 |
DK205988A (da) | 1988-05-31 |
KR880701601A (ko) | 1988-11-04 |
FI890782A0 (fi) | 1989-02-17 |
KR950009089B1 (ko) | 1995-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4925673A (en) | Delivery systems for pharmacological agents encapsulated with proteinoids | |
USRE35862E (en) | Delivery systems for pharmacological agents encapsulated with proteinoids | |
US4983402A (en) | Orally administerable ANF | |
US4976968A (en) | Anhydrous delivery systems for pharmacological agents | |
Ramadas et al. | Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats | |
US4855134A (en) | Sustained-release preparation | |
FI97691C (fi) | Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi | |
AU680408B2 (en) | Self-assembling diketopiperazine drug delivery system | |
US5679377A (en) | Protein microspheres and methods of using them | |
US5902606A (en) | Solid and liquid solutions of sparingly water-soluble medicinal substances | |
US6645525B1 (en) | Ionically formulated biomolecule microcarriers | |
US7976847B2 (en) | Controlled release CGRP delivery composition for cardiovascular and renal indications | |
JPH07508004A (ja) | プロテイノイド担体並びにその製造方法および使用方法 | |
JPH04503508A (ja) | 薬物送達組成物 | |
JPH0780782B2 (ja) | 貯蔵安定で認容性のエリトロポエチン製剤及びその製法 | |
WO1995022318A1 (en) | Drugs, vaccines and hormones in polylactide coated microspheres | |
EP0140255A2 (en) | Sustained-release injections | |
JPH0150686B2 (ko) | ||
EP0138216A2 (en) | Sustained-release IFN preparation for parenteral administration | |
JP2802488B2 (ja) | 経鼻吸収用生理活性ペプチド組成物 | |
IL104093A (en) | Prolamine is expected to mask the taste of drugs given orally | |
HU207439B (en) | Method for producing micro-capsuled medicine preparations | |
DE3745075C2 (de) | Mikroverkapselung für pharmakologische Mittel | |
JP2010514679A (ja) | 制御放出組成物及び方法 | |
PT86571B (pt) | Metodo para a microencapsulacao de agentes farmacologicos e processo para a preparacao de composicoes farmaceuticas que contem esses agentes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |